Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

AB Science suspends inclusion in masitinib trials

June 1, 2021

Inflammation, depression share "core biological process"

June 1, 2021

Shanghai SIMR Biotech synthesizes new PLA2G7 inhibitors

June 1, 2021

Chinese investigators disclose new componds for schizophrenia

May 31, 2021

Gene therapy can address infantile Parkinson's

May 31, 2021

DSMB recommends continuation of uniQure's phase I/II trial of AMT-130 in Huntington's disease

May 28, 2021

China NMPA approves CTA for phase IIb trial of AM-006 in Parkinson's disease

May 28, 2021

Gene signature governs anti-plaque microglia in AD

May 28, 2021

New opioid receptor agonists identified at Fudan University

May 27, 2021

FDA clears IND for phase I/II study of LION-101 gene therapy as treatment of LGMD2I/R9

May 27, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.